Immunization of pregnant women against pertussis: the effect of timing on antibody avidity
- PMID: 25744227
- DOI: 10.1016/j.vaccine.2015.02.059
Immunization of pregnant women against pertussis: the effect of timing on antibody avidity
Abstract
Background: The Centers for Disease Control and Prevention recommend tetanus-diphteria-acellular pertussis (Tdap) immunization during pregnancy, preferably at 27-36 weeks gestation.
Aims: First, to assess the relative avidity index (RAI) of umbilical cord immunoglobulin G (IgG) to pertussis toxin (PT) for newborns of women immunized with Tdap during late pregnancy as compared to unimmunized women. Second, to assess whether there is a preferential period of gestational Tdap immunization that provides the highest RAI of umbilical cord IgG to PT.
Methods: RAI of IgG to PT was assessed via an adapted ELISA using NH4SCN as a dissociating agent.
Results: We found that newborns of women immunized with Tdap during late pregnancy (n=52) had higher mean RAI of umbilical cord IgG to PT than those of unimmunized women (n=8), 73.77%±12.08 (95% CI, 70.41-77.13) vs. 50.23%±21.32 (95% CI, 32.41-68.06), p<0.001. Further, the RAI of umbilical cord IgG to PT was significantly higher in newborns of women immunized at 27-30(+6) weeks gestation (n=20) when compared with newborns of women immunized at 31-36 weeks (n=22) and >36 weeks (n=7), 79.53%±5.61 (95% CI, 76.91-82.16) vs. 71.56%±12.58 (95% CI, 65.98-77.14) vs. 63.93%±17.98 (95% CI, 47.31-80.56), p<0.03.
Conclusion: Gestational Tdap immunization between 27 and 30(+6) weeks resulted in the highest avidity of IgG to PT conveyed at delivery as compared with immunization beyond 31 weeks gestation. Future studies should be conducted to confirm our findings to optimize pertussis-controlling strategies.
Keywords: Immunoglobulin G; Pertussis; Pertussis toxin; Relative avidity index; Tetanus–diphtheria–acellular pertussis maternal immunization.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Comment in
-
The avidity of pertussis antibodies following gestational acellular pertussis immunization: Reply to Maertens.Vaccine. 2015 Oct 13;33(42):5490-5491. doi: 10.1016/j.vaccine.2015.05.090. Epub 2015 Jun 9. Vaccine. 2015. PMID: 26071193 No abstract available.
-
Avidity of maternal pertussis antibodies after vaccination during pregnancy.Vaccine. 2015 Oct 13;33(42):5489. doi: 10.1016/j.vaccine.2015.05.075. Epub 2015 Jun 24. Vaccine. 2015. PMID: 26116248 No abstract available.
Similar articles
-
The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels - a prospective study.Vaccine. 2014 Oct 7;32(44):5787-93. doi: 10.1016/j.vaccine.2014.08.038. Epub 2014 Aug 28. Vaccine. 2014. PMID: 25173476
-
The Effect of Timing of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administration in Pregnancy on the Avidity of Pertussis Antibodies.Front Immunol. 2019 Oct 11;10:2423. doi: 10.3389/fimmu.2019.02423. eCollection 2019. Front Immunol. 2019. PMID: 31681310 Free PMC article.
-
Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants.Clin Infect Dis. 2013 Feb;56(4):539-44. doi: 10.1093/cid/cis923. Epub 2012 Oct 24. Clin Infect Dis. 2013. PMID: 23097585
-
Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.Vaccine. 2012 Jul 27;30(35):5179-90. doi: 10.1016/j.vaccine.2012.06.005. Epub 2012 Jun 15. Vaccine. 2012. PMID: 22709953 Review.
-
Influenza and tetanus, diphtheria, and acellular pertussis vaccinations during pregnancy.Obstet Gynecol Surv. 2012 Apr;67(4):251-7. doi: 10.1097/OGX.0b013e3182524cee. Obstet Gynecol Surv. 2012. PMID: 22495061 Review.
Cited by
-
Decay Rates of Maternal Tetanus, Diphtheria, and Pertussis Antibody Levels in Early and Moderate-to-Late Preterm and Term Infants at Birth and at Two Months.Open Forum Infect Dis. 2024 Dec 10;12(1):ofae717. doi: 10.1093/ofid/ofae717. eCollection 2025 Jan. Open Forum Infect Dis. 2024. PMID: 39720465 Free PMC article.
-
One size fits all? Antibody avidity measurement against multiple antigens in maternal vaccination studies.Virulence. 2017 Oct 3;8(7):1066-1068. doi: 10.1080/21505594.2017.1321192. Epub 2017 Apr 25. Virulence. 2017. PMID: 28441089 Free PMC article. No abstract available.
-
Immunological and Clinical Benefits of Maternal Immunization Against Pertussis: A Systematic Review.Infect Dis Ther. 2019 Dec;8(4):499-541. doi: 10.1007/s40121-019-00264-7. Epub 2019 Sep 18. Infect Dis Ther. 2019. PMID: 31535327 Free PMC article. Review.
-
Are high avidity antibodies to Plasmodium falciparum antigens preferentially transferred across the placenta of premature and term babies?Placenta. 2023 Sep 7;140:11-19. doi: 10.1016/j.placenta.2023.07.011. Epub 2023 Jul 23. Placenta. 2023. PMID: 37515848 Free PMC article.
-
The Influence of Maternally Derived Antibody and Infant Age at Vaccination on Infant Vaccine Responses : An Individual Participant Meta-analysis.JAMA Pediatr. 2017 Jul 1;171(7):637-646. doi: 10.1001/jamapediatrics.2017.0638. JAMA Pediatr. 2017. PMID: 28505244 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical